These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1331480)

  • 1. Leukocytosis associated with all-trans-retinoic acid therapy in metastatic non-small-cell lung cancer.
    Kahn MJ; Luginbuhl W; Gaines L; Bratschi J; Bavaria J; Kaiser L; Treat J
    J Natl Cancer Inst; 1992 Nov; 84(21):1669-71. PubMed ID: 1331480
    [No Abstract]   [Full Text] [Related]  

  • 2. First hints in non-small cell lung cancer (NSCLC).
    Treat J; Greenberg R; Bratschi J; Gorman G; Meehan L; Friedland D
    Leukemia; 1994; 8 Suppl 3():S55-8. PubMed ID: 7808026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of all-trans retinoic acid in metastatic non-small cell lung cancer.
    Treat J; Friedland D; Luginbuhl W; Meehan L; Gorman G; Miller W; Bavaria J; Kaiser L
    Cancer Invest; 1996; 14(5):415-20. PubMed ID: 8816856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer.
    Athanasiadis I; Kies MS; Miller M; Ganzenko N; Joob A; Marymont M; Rademaker A; Gradishar WJ
    Clin Cancer Res; 1995 Sep; 1(9):973-9. PubMed ID: 9816069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I dose-finding and pharmacokinetic study of docetaxel and gefitinib in patients with advanced or metastatic non-small-cell lung cancer: evaluation of drug-drug interaction.
    Motonaga M; Yamamoto N; Makino Y; Ando-Makihara R; Ohe Y; Takano M; Hayashi Y
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):713-21. PubMed ID: 26233803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fatal side-effects of all-trans retinoic acid in the treatment of acute promyelocytic leukemia].
    Yang J; Han Z; Pei M; Xiao N
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):293-5. PubMed ID: 12016812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. True hypoglycaemia secondary to treatment with granulocyte colony stimulating factor (G-CSF) in a diabetic patient with non-small cell lung cancer.
    Coward JI; Nathavitharana R; Popat S
    Lung Cancer; 2012 Jan; 75(1):133-5. PubMed ID: 22126907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer.
    Okuma Y; Wakui H; Utsumi H; Sagawa Y; Hosomi Y; Kuwano K; Homma S
    Clin Lung Cancer; 2018 Sep; 19(5):410-417.e1. PubMed ID: 29859759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Kawaishi M; Fujiwara Y; Fukui T; Kato T; Yamada K; Ohe Y; Kunitoh H; Sekine I; Yamamoto N; Nokihara H; Watabe T; Shimoda Y; Arao T; Nishio K; Tamura T; Koizumi F
    J Thorac Oncol; 2009 Feb; 4(2):208-13. PubMed ID: 19179898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vitreous metastasis from lung cancer].
    Lemaitre S; Fereshteh F; Yin Y; Cassoux N
    J Fr Ophtalmol; 2014 Oct; 37(8):672-3. PubMed ID: 25199491
    [No Abstract]   [Full Text] [Related]  

  • 11. The value of serum Bcl-2 levels in advanced lung cancer patients.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Oral EN; Yasasever V; Topuz E
    Med Oncol; 2005; 22(2):139-43. PubMed ID: 15965276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum retinoic acid, retinol and retinyl palmitate levels in patients with lung cancer.
    Moulas AN; Gerogianni IC; Papadopoulos D; Gourgoulianis KI
    Respirology; 2006 Mar; 11(2):169-74. PubMed ID: 16548902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraventricular chemotherapy for leptomeningeal carcinomatosis from lung cancer: a feasible and beneficial treatment option?
    Christoph DC; Reckamp KL
    J Thorac Oncol; 2013 May; 8(5):523-4. PubMed ID: 23584292
    [No Abstract]   [Full Text] [Related]  

  • 14. Retinoic acid syndrome during the treatment of acute myelomonocytic leukaemia with all-trans-retinoic acid and low-dose cytosine arabinoside.
    Nagafuji K; Eto T; Tokunaga Y; Hayashi S; Niho Y
    Br J Haematol; 1998 Mar; 100(3):610-1. PubMed ID: 9504655
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4.
    Miura N; Kamita M; Kakuya T; Fujiwara Y; Tsuta K; Shiraishi H; Takeshita F; Ochiya T; Shoji H; Huang W; Ohe Y; Yamada T; Honda K
    Oncotarget; 2016 May; 7(22):33165-78. PubMed ID: 27121206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen as prognostic factor for metastatic non-small cell lung cancer by percutaneous cryosurgery.
    Li H; Tang K; Niu L; Liang Y; Li J; Chen J; Xu K
    Cancer Biomark; 2013; 13(5):337-43. PubMed ID: 24440973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dry extract of Scutellaria baicalensis as a hemostimulant in antineoplastic chemotherapy in patents with lung cancer].
    Gol'dberg VE; Ryzhakov VM; Matiash MG; Stepovaia EA; Boldyshev DA; Litvinenko VI; Dygaĭ AM
    Eksp Klin Farmakol; 1997; 60(6):28-30. PubMed ID: 9460593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
    Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G
    Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of biomarkers of therapeutic effects of patients with lung adenocarcinoma treated with gefitinib based on progression-free-survival by metabolomic fingerprinting.
    Zhuang J; Tang X; Du Z; Yang M; Zhou Y
    Talanta; 2016 Nov; 160():636-644. PubMed ID: 27591660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF-Mutated Lung Adenocarcinoma.
    Guibert N; Pradines A; Casanova A; Farella M; Keller L; Soria JC; Favre G; Mazières J
    J Thorac Oncol; 2016 Sep; 11(9):e109-12. PubMed ID: 27165943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.